|
RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers Clinical research trials and RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers. RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers clinical trial. Participants oftentimes recieve the most expert healthcare available for their RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "R" Clinical Trials Conditions > RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers  RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers
RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers
For Condition: Diabetic Foot
Status: Recruiting
Sponsor(s): Genentech ,
Synopsis: The purpose of this study is to assess the safety of telbermin applied topically to chronic, diabetic foot ulcers and to explore the possible effectiveness of this treatment to induce healing of diabetic foot ulcers.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/80 Years
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA - Type 1 or 2 diabetes mellitus. - Single, full-thickness (i.e. extending into the subcutaneous tissue or beyond) ulcer of the foot that does not involve bone, tendons, ligaments, or muscle below the malleolus. - Chronic ulcer with a duration of >4 weeks but <6 months. EXCLUSION CRITERIA - History of neoplasia or current neoplasia (with the exception of non-melanoma skin cancer). - Proliferative diabetic retinopathy or wet age-related macular degeneration. - Active ulcer infection or cellulitis of any ulcer. - Immunosuppressive treatment, including radiation therapy, corticosteroids, and chemotherapy. - Pregnancy or lactation. - Multiple ulcers in the study foot. - Known prior inability to complete required study visits during treatment period. - Current use of any other investigational drug. - Previous use of a platelet-derived or other growth factors on the study ulcer within the past 3 months.
Total Enrollment:
Location and Contact Information:
Trial Information Support Center *Recruiting*
Denver, Colorado,
United States
Recruiting Support Staff 888-662-6278
Additional Information:
Study ID Numbers: VGF2763g;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00069446
Other Diabetic Foot Studies:
1. RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers
Related Studies:
Other Diabetic Foot Clinical Trials
Other Colorado Clinical Trials
Other Denver Clinical Trials
RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers
|
|
|
|
|
|
|
|
